FDA 483 - Sovereign Pharmaceuticals, LLC - September 01, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Sovereign Pharmaceuticals, LLC, a contract manufacturer in Fort Worth, TX, revealed significant deficiencies across its quality system, laboratory controls, and production records. The firm failed to follow its own quality unit procedures, lacked adequate written procedures for data reprocessing and microbial identification, and released drug products from a failed blend uniformity lot. Additionally, master production records were found to be incomplete, omitting a routine manufacturing step.
ID · afd44703-d002-4c2f-9ae9-3a19c48695d5